News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Johnson & Johnson (JNJ) Bets $700 Million on MacroGenics, Inc. (MGNX)'s Blood Cancer Drug     12/22/2014
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall     12/22/2014
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD)     12/22/2014
AstraZeneca PLC (AZN) CEO Believes New Pfizer (PFE) Bid Unlikely     12/22/2014
FDA Approves AbbVie (ABBV)'s All-Oral Hepatitis C Drug Viekira Pak     12/22/2014
FDA Approves Biocryst Pharmaceuticals (BCRX)'s Intravenous Flu Drug Rapivab     12/22/2014
AstraZeneca PLC (AZN) Grabs Accelerated FDA Approval for Lynparza     12/22/2014
Achillion Pharmaceuticals, Inc. (ACHN) Surges as Potential Drug Combo Seen as Hepatitis C Cure     12/22/2014
Big Pharmas Like Johnson & Johnson (JNJ), Boehringer Ingelheim Corporation. Eli Lilly (LLY), and Roche (RHHBY) are Shedding Jobs in Korea     12/22/2014
Phylogica Ltd. Grabs $142 Million Deal With Genentech (RHHBY)     12/22/2014
NewLink Genetics, Merck & Co. (MRK) Nabs $30 Million Government Contract For Ebola     12/22/2014
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/19/2014
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys     12/19/2014
Merck & Co. (MRK) Snaps Up Swiss Biotech In $375 Buyout Deal     12/19/2014
AstraZeneca PLC (AZN) To Slash 250 Jobs As Another Plant Faces Shutdown     12/19/2014

Featured Stories
Shocking Truth About Race In White People’s DNA Uncovered, Harvard University Study     12/22/2014
A Hug A Day May Keep Stress And Sickness Away, Say Carnegie Mellon University Researchers     12/22/2014
Blood Type May Raise Diabetes Risk, INSERM Study     12/22/2014
Young Kids With Type 1 Diabetes Have Slower Brain Growth, Nemours Children's Clinic Study     12/22/2014
Parkinson’s Disease Reverted At A Experimental Stage, CINVESTAV Study     12/22/2014
Why Smartphone Scent Transmission Will Not Be The Next Big Thing     12/22/2014
Even More Reasons To Treat OCD Early, University of Cambridge Reveals     12/22/2014
Bacterial Infections Differ Based On Where You Live, Rhode Island Hospital Researchers Reveal     12/22/2014
How We Grin To Bear It—The Science Of Smiling     12/22/2014
AIDS Drug Also Offers Protection Against Malaria, Yale University Study Finds     12/22/2014
The Ebola Treatment You Know Nothing About     12/19/2014
Ibuprofen May Be The Key To Anti-Aging, Buck Institute for Age Research Study     12/19/2014
OTC Painkillers Linked To Reduced Skin Cancer Risk, University of London Study     12/19/2014
Heart Drugs Of The Year: New, Old, And Not-So-Funny     12/19/2014
Low-Dose Lithium Prevents Parkinson's Symptoms In Aged Mice With A Human Mutation For The Disease, Buck Institute for Age Research Study     12/19/2014

More News
AbbVie (ABBV) Receives U.S. FDA Approval Of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) For The Treatment Of Chronic Genotype 1 Hepatitis C     12/22/2014
Biocryst Pharmaceuticals (BCRX)'s RAPIVAB™ (Peramivir Injection) Receives FDA Approval For The Treatment Of Acute Uncomplicated Influenza     12/22/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi)     12/22/2014
AstraZeneca PLC (AZN) Release: LYNPARZA™ Approved By The FDA For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-Mutations     12/22/2014
LYNPARZA™ (Olaparib) Approved For The Treatment Of Advanced Relapsed Ovarian Cancer In Patients With Germline BRCA Mutations, Available Exclusively At Biologics, Inc. (NC)     12/22/2014
Cubist Pharmaceuticals, Inc. (CBST) Announces FDA Approval Of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) For Complicated Urinary Tract And Complicated Intra-abdominal Infections     12/22/2014
Enanta Pharmaceuticals, Inc. Announces FDA Approves AbbVie (ABBV)’s VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) For The Treatment Of Chronic Genotype 1 Hepatitis C Virus     12/22/2014
Taiho Oncology Completes Submission Of TAS-102 New Drug Application To The US FDA For The Treatment Of Refractory Metastatic Colorectal Cancer     12/22/2014
Pharmacyclics, Inc. (PCYC) Announces Update On IMBRUVICA® (Ibrutinib) Waldenstrom's Macroglobulinemia (WM) Submission     12/22/2014
Actavis (ACT) Release: XYDALBA™ (dalbavancin) Receives CHMP Positive Opinion For The Treatment Of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) In Adults     12/22/2014
Auxilium Pharmaceuticals (AUXL) Release: Sobi's Xiapex Receives Positive Opinion By CHMP For The Treatment Of Peyronie's Disease     12/22/2014
Jaguar Animal Health Initiates Filing Of Its First New Animal Drug Application With FDA     12/22/2014
Ligand Pharmaceuticals Inc. (LGND) Partner GlaxoSmithKline (GSK) Announces US Regulatory Submission Seeking Additional Indication For Promacta®     12/22/2014
Baxter International, Inc. (BAX) Submits Application For U.S. FDA Approval Of BAX111, Investigational Recombinant Treatment For Von Willebrand Disease     12/22/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Designation With The European Medicines Agency For Pancreatic And Ovarian Cancers     12/22/2014
Eiger Bio Receives Orphan Designation For Lonafarnib, A First In Class, Investigational Treatment For Hepatitis Delta Virus (HDV) Infection     12/22/2014
Provectus Biopharmaceuticals Inc. To Meet With FDA On Operational Aspects Of PV-10 Phase 3 Melanoma Study With Aim To Maximize Speed Of Enrollment     12/22/2014
TiGenix Submits Its Pivotal US Trial Design For Cx601 To FDA For Special Protocol Assessment     12/22/2014
Receptos (RCPT) Initiates SUNBEAM Phase 3 Trial Of RPC1063 In Relapsing Multiple Sclerosis     12/22/2014
Radius (RDUS) Announces Positive Phase 3 Top-Line Results For Its Investigational Drug Abaloparatide-SC In Postmenopausal Women With Severe Osteoporosis     12/22/2014
TiGenix Submits Its Pivotal US Trial Design For Cx601 To The FDA For Special Protocol Assessment     12/22/2014
VBL Therapeutics (VBLX) Announces Positive Phase 2a Data For VB-111 In Recurrent Thyroid Cancer     12/22/2014
Achillion Pharmaceuticals, Inc. (ACHN) Shows Potential For "Best-In-Disease" HCV Regimen - 100% SVR4 Following A Dual 6-Week ACH-3102-Based Regimen And Separately A 4.8 Log10 Reduction With ACH-3422     12/22/2014
FDA Grants Orphan Drug Designation To Nuvilex (NVLX) For Pancreatic Cancer Treatment     12/22/2014
Can-Fite BioPharma (CFBI) Doses First Patient In Global Phase 2 Liver Cancer Trial For CF102     12/22/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Reaches Response Milestone In Phase 2 Clinical Trial Of Pracinostat In Refractory Myelodysplastic Syndrome     12/22/2014
MediGene AG (MDGEF.PK) Receives Clinical Trial Approval For Phase I/II Study With DC Vaccine To Treat Acute Myeloid Leukaemia (AML)     12/22/2014
Cerus Corporation (CERS) Reports U.S. Phase 2 Clinical Trial Of INTERCEPT Red Blood Cells Met Primary Endpoint     12/22/2014
Relmada Therapeutics Doses First Cohort Of Subjects In Human Clinical Trial Of D-Methadone     12/22/2014
AGA's GERD Registry Enrolls First Patients     12/22/2014
New Published Data Show Pluristem Therapeutics (PSTI)'s PLX Cells Protect Neurons     12/22/2014
Synthetic Biologics, Inc. (SYN) Announces Positive Topline Results From Phase 1a Trial Of SYN-004 For The Prevention Of C. Difficile Infection     12/22/2014
Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use Of Dermal Sheath Cup Cells To Treat Pattern Baldness     12/22/2014
Tekmira (TKMR) Receives Clearance To Conduct A Phase I Clinical Study With TKM-HBV     12/22/2014
ContraFect Corporation (CFRXU) Receives FDA Approval to Initiate Clinical Trials of CF-301 for MRSA Bloodstream Infections     12/22/2014
FDA Accepts IND Application For Radius (RDUS)'s Investigational Drug RAD1901 Being Developed For Potential Use In Metastatic Breast Cancer     12/22/2014
Pfenex Inc. (PFNX) Announces Active IND And Additional BARDA Funding For Recombinant Anthrax Vaccine Program, Px563L     12/22/2014
Bio-Path Holdings, Inc. (BPTH) To Initiate Development Of Liposomal Bcl-2 In Follicular Lymphoma     12/22/2014
Medivir AB (MVRBF): MIV-802 Has Been Selected As A Candidate Drug And Enters Non-Clinical Development For The Treatment Of Hepatitis C Infection     12/22/2014
The Scripps Research Institute Scientists Uncover New, Fundamental Mechanism For How Resveratrol Provides Health Benefits     12/22/2014
H. Lundbeck A/S (LUN.CO) To Research Link Between Immune System And Brain Diseases     12/22/2014
Okayama University Research: Cardiac Mechanosensitive Integrator     12/22/2014
GenomeDx Biosciences Release: Study Published In European Urology Shows That The Decipher Prostate Cancer Classifier Is Predictive Of Rapid Metastasis In High-Risk Men Who Have Had Prostate Surgery     12/22/2014
Mederi Therapeutics Inc. Release: Groundbreaking Study Demonstrates Dramatic Histopathological Changes With Stretta And Secca     12/22/2014
Sartorius To Sell Its Industrial Technologies Division To Minebea Co., Ltd.     12/22/2014
Amgen (AMGN) Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts     12/22/2014
EpiVax, Inc. Enters License Agreement With Novozymes Biopharma To Advance Pioneering Treatment Of Autoimmune Diseases     12/22/2014
Micron And A*STAR Data Storage Institute Renew Research Collaboration     12/22/2014
Tiziana Life Sciences Plc Licenses Foralumab From NovImmune SA     12/22/2014
Sevion Announces Antibody Discovery Collaboration With Johnson & Johnson Innovation (JNJ) And Janssen Pharmaceutical Inc.     12/22/2014
ADDC And AstraZeneca PLC (AZN) Collaborate To Support Five High Throughput Screening Proposals For New Therapeutic Targets     12/22/2014
Eli Lilly (LLY) Announces Diabetes Research Partnership With University of Surrey     12/22/2014
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With MSN Laboratories Pvt. Ltd.     12/22/2014
Tekmira (TKMR) Establishes Manufacturing And Clinical Trial Agreement To Provide TKM-Ebola-Guinea For Clinical Studies In West Africa     12/22/2014
Evotec AG (EVTG.F) And Ohio State University To Collaborate On Novel Cancer Therapy     12/22/2014
Advanced Medical Isotopes Corporation Awarded Life Sciences Discovery Fund Grant As Commercialization Partner     12/22/2014
Hospira Foundation Announces The Leukemia & Lymphoma Society As Winner Of $100,000 (Mission: Care)2 Grant     12/22/2014
TWi Pharmaceuticals, Inc. Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In China     12/22/2014
Mylan Inc. (MYL) Launches First Generic Version Of Vivelle-DOT®     12/22/2014
Prima Biomed (PRR.AX) Announces Immutep's IMP321 Patent Application Receives Canadian Patent Office Notice Of Grant     12/22/2014
Keryx Biopharmaceuticals (KERX) Announces Commercial Launch Of AURYXIA™ (Ferric Citrate) Tablets In The United States     12/22/2014
Nuvo Research Inc. (NRI.TO) Granted Additional U.S. Patent For Treatment Of Allergic Rhinitis With WF10     12/22/2014
Amarantus BioSciences, Inc. Commences Launch Of Proprietary Alzheimer's Blood Diagnostic Lympro Test® To Pharmaceutical Industry For Use In Clinical Trials     12/22/2014
Advaxis, Inc. Completes $17 Million Financing     12/22/2014
Parnell Pharmaceuticals Holdings Management Adopts 10b5-1 Trading Plans     12/22/2014
Dermira Added To Russell 2000® Index     12/22/2014
Amicus Therapeutics, Inc. (FOLD) Added To NASDAQ Biotechnology Index (NBI)     12/22/2014
GW Pharmaceuticals Added To NASDAQ Biotechnology Index     12/22/2014
Concord Medical Services Holdings Limited (CCM) To Hold Annual General Meeting On January 27, 2015     12/22/2014
RXi Pharmaceuticals (RXII) Issues Open Letter To Shareholders     12/22/2014
Rhinomed (ASX:RNO) R&D Tax Incentive Of $570k Received To Support Development     12/22/2014
InSite Vision (ISV) Announces Date For Annual Stockholder Meeting     12/22/2014
Apricus Biosciences (APRI) Announces Year-End 2014 Update And 2015 Plans To Advance Its Clinical Pipeline And Further Commercialize Its Erectile Dysfunction Drug Vitaros®     12/22/2014
BASi (BASI) Reports Fourth Quarter And Full Year 2014 Results     12/22/2014
Aegate Appoints New CTO And Chief Channels & Partner Officer     12/22/2014
N30 Pharma Appoints Jon Congleton As President And CEO     12/22/2014
Actavis (ACT) Names Jonathon Kellerman Executive Vice President, Global Chief Compliance Officer     12/22/2014
ImmunoGen, Inc. (IMGN) Appoints Richard J. Gregory, Ph.D. As EVP, Chief Scientific Officer; John M. Lambert, Ph.D. Named EVP, Distinguished Research Fellow     12/22/2014
CytoSorbents, Inc. Appoints Dr. Gregory B. Di Russo As Senior Vice President Of Clinical Development     12/22/2014
Albert Einstein College of Medicine And Montefiore Health System Name New Chair Of Obstetrics & Gynecology And Women's Health     12/22/2014
Concordia Healthcare Corp (CXR.TO) Announces Change To Board Of Directors     12/22/2014
Invacare Corporation (IVC) Announces Interim Chairman Of The Board Of Directors     12/22/2014
Seven More Research Organizations Earn AAHRPP Accreditation, Including First In Thailand     12/22/2014
Colorado BioScience Association Release: 2014 Proves A Successful Year For Major Bioscience Fundings, Including Key Merger And Acquisition Activity In Colorado     12/22/2014
Teva Pharmaceutical Industries Limited (TEVA) To Present At The Goldman, Sachs & Co. Healthcare Ceos Unscripted Conference     12/22/2014
Simulations Plus (SLP) To Present At The Sidoti & Company Emerging Growth Institutional Investor Forum On January 12, 2015     12/22/2014
61st Annual Free Care Fund Benefit Show On KDKA Showcases More Than $2.1 Million Raised For Children's Hospital Of Pittsburgh Foundation     12/22/2014
Eiger Bio Announces Positive Data In Patients Infected With Hepatitis Delta Virus (HDV) Treated With Lonafarnib - Results Presented At American Association for Study of Liver Diseases Meeting     12/22/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At Biotech Showcase In San Francisco     12/22/2014
BrainStorm Cell Therapeutics Inc. To Host Conference Call To Discuss Final Results Of Phase 2a Trial Of NurOwn™ In ALS On January 5, 2015     12/22/2014
Ariad Pharmaceuticals, Inc. (ARIA) To Present At The 33rd Annual J.P. Morgan Healthcare Conference     12/22/2014
Henry Schein, Inc. (HSIC) To Present At The 33rd Annual J.P. Morgan Healthcare Conference     12/22/2014
Hospira, Inc. To Present At The J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015     12/22/2014
Amicus Therapeutics, Inc. (FOLD) To Present Program Updates At 33rd Annual J.P. Morgan Healthcare Conference     12/22/2014
Illumina (ILMN) To Webcast Live Presentation At The J.P. Morgan Annual Healthcare Conference     12/22/2014
Actavis (ACT)To Present At 33rd Annual J.P. Morgan Healthcare Conference     12/22/2014
Week in Review: China's Neusoft Raises $610 Million For Life Science Subsidiaries     12/22/2014

Career Tips
How To Get Noticed By Employers: Advice From Cliniqa And DexCom (DXCM)     12/18/2014
Best Cover Letter Tips For 2015     12/18/2014
Top 10 Resume Tips For 2015     12/18/2014
5 Crucial Cover Letter Mistakes     12/18/2014
What AstraZeneca PLC (AZN) Is Looking For In Hiring Scientists And Execs     12/5/2014
3 Cover Letter Mistakes You May Not Realize You've Made     12/4/2014
5 Myths About HR During The Job Inteview Debunked     12/4/2014
Avoid These 4 Common Resume Flaws     12/4/2014
Top 10 Biotech Careers Ranked     12/3/2014
Ardea Biosciences, Inc. HR VP Shares A Fool-Proof Guide To Joining A Startup     11/20/2014
3 Signs Your Resume Isn't Working     11/20/2014
3 Deadly Mistakes Made In Job Interviews     11/20/2014
4 Essentials Of A Good Cover Letter     11/20/2014
Sanofi (SAN.PA) And Incyte Corporation (INCY) Execs Exclusive: Future Hiring Trends And What They're Looking For In New Hires     11/7/2014
4 Common Mistakes That Sabotage Your Resume     11/6/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->